Topical fentanyl in a randomized, double-blind study in patients with corneal damage

Clinical Journal of Pain

Volumn 24, Issue 8, 2008, Pages 690-696

  Zöllner, Christian ^a   Mousa, Shaaban ^a   Klinger, Astrid ^a   Förster, Michael ^a   Schäfer, Michael ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Corneal erosion; Nerve fibers; Opioid receptor; Pain; Topical application

Indexed keywords

DELTA OPIATE RECEPTOR; DEXPANTHENOL; FENTANYL; MU OPIATE RECEPTOR; DRUG DERIVATIVE; NARCOTIC ANALGESIC AGENT; PANTOTHENIC ACID;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA EROSION; CORNEA INJURY; CORNEA SURGERY; DOUBLE BLIND PROCEDURE; EXPERIMENT; EYE PAIN; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOCAL ANESTHESIA; NERVE FIBER; PAIN; PERIPHERAL NERVE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; STAINING; AGED; CORNEA DISEASE; DRUG ADMINISTRATION; FEMALE; MALE; METABOLISM; MIDDLE AGED; PAIN ASSESSMENT; TIME; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; AGED; ANALGESICS, OPIOID; CORNEAL DISEASES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FENTANYL; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PANTOTHENIC ACID; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU; TIME FACTORS;

EID: 58149402712     PISSN: 07498047     EISSN: 15365409     Source Type: Journal    
DOI: 10.1097/AJP.0b013e318175929e     Document Type: Article

References (50)

1. Peyman GA, Rahimy MH, Fernandes ML. Effects of morphine on corneal sensitivity and epithelial wound healing: implications for topical ophthalmic analgesia. Br J Ophthalmol. 1994;78:138141.
2. Stiles J, Honda CN, Krohne SG, et al. Effect of topical administration of 1% morphine sulfate solution on signs of pain and corneal wound healing in dogs. Am J Vet Res. 2003;64:813818.
3. Stein C, Scha fer M, Machelska H. Attacking pain at its source: new perspectives on opioids. Nat Med. 2003;9:10031008.
4. Schafer MK, Bette M, Romeo H, et al. Localization of kappaopioid receptor mRNA in neuronal subpopulations of rat sensory ganglia and spinal cord. Neurosci Lett. 1994;167:137140.
5. Puehler W, Zo llner C, Brack A, et al. Rapid upregulation of m opioid receptor mRNA in dorsal root ganglia in response to peripheral inflammation depends on neuronal conduction. Neuroscience. 2004;129:473479.
6. Chen JJ, Dymshitz J, Vasko MR. Regulation of opioid receptors in rat sensory neurons in culture. Mol Pharmacol. 1997;51:666673.
7. Zo llner C, Shaqura MA, Bopaiah CP, et al. Painful inflammationinduced increase in mu-opioid receptor binding and G-protein coupling in primary afferent neurons. Mol Pharmacol. 2003;64:202210.
8. Shaqura MA, Zo llner C, Mousa SA, et al. Characterization of mu opioid receptor binding and G protein coupling in rat hypothalamus, spinal cord, and primary afferent neurons during inflammatory pain. J Pharmacol Exp Ther. 2004;308:712718.
9. Ingram SL, Williams JT. Opioid inhibition of Ih via adenylyl cyclase. Neuron. 1994;13:179186.
10. Gold MS, Levine JD. DAMGO inhibits prostaglandin E2-induced potentiation of a TTX-resistant Na+ current in rat sensory neurons in vitro. Neurosci Lett. 1996;212:8386.
11. Schroeder JE, McCleskey EW. Inhibition of Ca2+ currents by a m-opioid in a defined subset of rat sensory neurons. J Neurosci. 1993;13:867873.
12. Endres-Becker J, Heppenstall PA, Mousa SA, et al. Mu-opioid receptor activation modulates transient receptor potential vanilloid 1 (TRPV1) currents in sensory neurons in a model of inflammatory pain. Mol Pharmacol. 2007;71:1218.
13. Wenk HN, Nannenga MN, Honda CN. Effect of morphine sulphate eye drops on hyperalgesia in the rat cornea. Pain. 2003;105:455465.
14. Andreev N, Urban L, Dray A. Opioids suppress spontaneous activity of polymodal nociceptors in rat paw skin induced by ultraviolet irradiation. Neuroscience. 1994;58:793798.
15. Charlton E. Ethical guidelines for pain research in humans. Committee on Ethical Issues of the International Association for the Study of Pain. Pain. 1995;63:277278.
16. Mousa SA, Machelska H, Scha fer M, et al. Co-expression of betaendorphin with adhesion molecules in a model of inflammatory pain. J Neuroimmunol. 2000;108:160170.
17. Mousa SA, Zhang Q, Sitte N, et al. Beta-Endorphin-containing memory-cells and mu-opioid receptors undergo transport to peripheral inflamed tissue. J Neuroimmunol. 2001;115:7178.
18. Brack A, Rittner HL, Machelska H, et al. Mobilization of opioidcontaining polymorphonuclear cells by hematopoietic growth factors and influence on inflammatory pain. Anesthesiology. 2004;100:149157.
19. Gobbels M, Gross D. Clinical study of the effectiveness of a dexpanthenol containing artificial tears solution (Siccaprotect) in treatment of dry eyes. Klin Monatsbl Augenheilkd. 1996;209:8488.
20. Haselmann G, Pulfrich K, Haselmann H. Treatment of epithelial lesions of the cornea. Ophthalmologica. 1952;123:357364.
21. Egger SF, Huber-Spitzy V, Alzner E, et al. Corneal wound healing after superficial foreign body injury: vitamin A and dexpanthenol versus a calf blood extract. A randomized double-blind study. Ophthalmologica. 1999;213:246249.
22. Rozsa AJ, Beuerman RW. Density and organization of free nerve endings in the corneal epithelium of the rabbit. Pain. 1982;14:105120.
23. Muller LJ, Marfurt CF, Kruse F, et al. Corneal nerves: structure, contents and function. Exp Eye Res. 2003;76:521542.
24. Tervo K, Tervo T, Eranko L, et al. Substance P-immunoreactive nerves in the human cornea and iris. Invest Ophthalmol Vis Sci. 1982;23:671674.
25. Jones MA,Marfurt CF. Calcitonin gene-related peptide and corneal innervation: a developmental study in the rat. J Comp Neurol. 1991;313:132150.
26. Wenk HN, Honda CN. Immunohistochemical localization of delta opioid receptors in peripheral tissues. J Comp Neurol. 1999;408:567579.
27. Jongkamonwiwat N, Phansuwan-Pujito P, Sarapoke P, et al. The presence of opioid receptors in rat inner ear. Hear Res. 2003;181:8593.
28. Craft RM, Henley SR, Haaseth RC, et al. Opioid antinociception in a rat model of visceral pain: systemic versus local drug administration. J Pharmacol Exp Ther. 1995;275:15351542.
29. Twillman RK, Long TD, Cathers TA, et al. Treatment of painful skin ulcers with topical opioids. J Pain Symptom Manage. 1999;17:288292.
30. Stein C, Schafer M, Hassan AH. Peripheral opioid receptors. Ann Med. 1995;27:219221.
31. Fristad I, Berggreen E, Haug SR. Delta opioid receptors in small and medium-sized trigeminal neurons supporting the dental pulp of rats. Arch Oral Biol. 2006;51:273281.
32. Stein C. The control of pain in peripheral tissue by opioids. N Engl J Med. 1995;332:16851690.
33. Bertschy C, Aubert D, Lassauge F, et al. Intravesical morphine analgesia in pediatric urology. Prog Urol. 1999;9:474478.
34. Duckett JW, Cangiano T, Cubina M, et al. Intravesical morphine analgesia after bladder surgery. J Urol. 1997;157:14071409.
35. Likar R, Sittl R, Gragger K, et al. Peripheral morphine analgesia in dental surgery. Pain. 1998;76:145150.
36. Likar R, Schafer M, Paulak F, et al. Intraarticular morphine analgesia in chronic pain patients with osteoarthritis. Anesth Analg. 1997;84:13131317.
37. Kolesnikov YA, Chereshnev I, Pasternak GW. Analgesic synergy between topical lidocaine and topical opioids. J Pharmacol Exp Ther. 2000;295:546551.
38. Long TD, Cathers TA, Twillman R, et al. Morphine-infused silver sulfadiazine (MISS) cream for burn analgesia: a pilot study. J Burn Care Rehabil. 2001;22:118123.
39. Krajnik M, Zylicz Z, Finlay I, et al. Potential uses of topical opioids in palliative care-report of 6 cases. Pain. 1999;80:121125.
40. Jagerovic N, Cano C, Elguero J, et al. Long-acting fentanyl analogues: synthesis and pharmacology of N-(1-phenylpyrazolyl)- N-(1-phenylalkyl-4- piperidyl) propanamides. Bioorg Med Chem. 2002;10:817827.
41. Lee YS, Nyberg J, Moye S, et al. Understanding the structural requirements of 4-anilidopiperidine analogues for biological activities at mu and delta opioid receptors. Bioorg Med Chem Lett. 2007;17:21612165.
42. Antonijevic I, Mousa SA, Scha fer M, et al. Perineurial defect and peripheral opioid analgesia in inflammation. J Neurosci. 1995;15:165172.
43. Muijsers RB, Wagstaff AJ. Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control. Drugs. 2001;61:22892307.
44. Dale O, Hjortkjaer R, Kharasch ED. Nasal administration of opioids for pain management in adults. Acta Anaesthesiol Scand. 2002;46:759770.
45. Mystakidou K, Katsouda E, Parpa E, et al. Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: an overview of its pharmacological and clinical characteristics. Am J Hosp Palliat Care. 2005;22:228232.
46. Zague V, Polacow ML, Pires-de-Campos MS, et al. Evaluation of the ultrasound influence in the cutaneous penetration of d-panthenol: test in vitro. J Cosmet Dermatol. 2005;4:2933.
47. Ebner F, Heller A, Rippke F, et al. Topical use of dexpanthenol in skin disorders. Am J Clin Dermatol. 2002;3:427433.
48. Valenta C, Dabic T. Effect of urea and pantothenol on the permeation of progesterone through excised rat skin from polymer matrix systems. Drug Dev Ind Pharm. 2001;27:5762.
49. Chast F, Bardin C, Sauvageon-Martre H, et al. Systemic morphine pharmacokinetics after ocular administration. J Pharm Sci. 1991;80:911917.
50. Zagon IS, Sassani JW, McLaughlin PJ. Reepithelialization of the human cornea is regulated by endogenous opioids. Invest Ophthalmol Vis Sci. 2000;41:7381.